Download PDF
Vet Comp Orthop Traumatol 1999; 12(01): 48-55
DOI: 10.1055/s-0038-1632558
Original Research
Schattauer GmbH

The Effects of Polysulphated Glycosaminoglycan on the Healing of Collagenase Induced Tendinitis

W. R. Redding
1   From the Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA
,
L. C. Booth
1   From the Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, USA
,
R. R. Pool
2   Department of Pathology, University of California at Davis, Davis, CA, USA
› Author Affiliations
Further Information

Publication History

Received:01 November 1996

Accepted:01 April 1998

Publication Date:
10 February 2018 (online)

    Permissions and Reprints

Summary

Objective. To examine the effects of polysulphated glycosaminoglycan on tendon healing in a controlled collagenase injury model. Design. The study used a completely randomized design with four horses assigned to each of two groups, control and treated. The superficial digital flexor tendons from each horse were measured weekly by ultrasound techniques. The differences between groups were evaluated using t-statistics and trends summarized by simple linear regression. Animals. Eight horses (four Thoroughbreds and four Standardbreds) with normal superficial flexor tendons were divided into two groups of four. Group #1 control horses were not treated. Group #2 horses were treated with polysulphated glycosaminoglycans. Procedure. All of the horses had tendinitis induced in the superficial flexor tendon of both forelimbs by the injection of 4000 IU of collagenase. The treated group received 500 mg of polysulphated glycosaminoglycan (PSGAG) IM every five days for seven treatments beginning 24 h after injection of collagenase. The control group received saline at the same time periods. Ultrasound examination of each limb was performed on days 1, 3, 5, and 7 post-injection and weekly thereafter for eight weeks. An image analysis system was used to measure the proportion of tendon area damaged in mm2 on the recorded images, and these values were plotted over time. The horses were euthanatized at eight weeks and histological evaluation was performed on longitudinal sections of excised tendons. Results. The size of the tendon core defects created by the collagenase enzyme, represented as the proportion of area damaged, decreased significantly faster in the treatment group (ρ <0.01). Histologic evaluation of the core defects confirmed what was seen sonographically. Conclusion. Polysulphated glycosaminoglycans had a positive effect on tendon healing in a collagenase induced tendinitis model. Clinical relevance. Polysulphated glycosaminoglycans may be beneficial in managing clinical cases of tendinitis.

Eight horses had experimental core defects induced in the superficial digital flexor tendon of both forelimbs. One group of four horses received PSGAG IM every 5 days for seven treatments. The control group received saline. The core defects in the PSGAG treatment group developed echogenic ultrasound patterns earlier, and the mean ratio of area of the tendon decreased significantly faster in the treatment group.

Keywords

Polysulfated glycosaminoglycan - tendinitis - ultrasound
 

  • REFERENCES

  • 1 Silver IF, Brown PN, Goodship AE. et al Studies on the pathogenesis of equine tendinitis following collagenase injury. Equine Vet J 1983; Suppl (Suppl. 01) 1: 43.
    PubMedGoogle Scholar
  • 2 Spurlock GH, Spurlock SL, Parker GA. Ultrasonographic, gross, and histologic evaluation of a tendinitis disease model in the horse. Vet Radiology 1989; 30: 184-8.
    PubMedGoogle Scholar
  • 3 Williams IF, McCullagh KG, Silver IA. The distribution of types 1 and 111 collagen and fibronectin in the healing equine tendon. Connect Tiss Res 1984; 12: 211-27.
    CrossrefPubMedGoogle Scholar
  • 4 Williams IF, McCullagh KG. Goodship AE. et al Studies on the pathogenesis of equine tendinitis following collagenase injury. Res Vet Sci 1984; 36: 326-38.
    PubMedGoogle Scholar
  • 5 Spurlock GH, Spurlock SL, Parker GA. Evaluation of hylartin v therapy for induced tendinitis in the horse. Eq Vet Sci 1989; 9: 242-6.
    CrossrefPubMedGoogle Scholar
  • 6 Gaughan EM, Nixon AJ, Lennart PK. et al Effects of sodium hyaluronate on tendon healing and adhesion formation in horses. Am J Vet Res 1991; 52: 764-73.
    PubMedGoogle Scholar
  • 7 Foland JW, Trotter GW, Powers BE. et al Effect of sodium hyaluronate in collagenaseinduced superficial digital flexor tendinitis in horses. Am J Vet Res 1992; 53: 2371-6.
    PubMedGoogle Scholar
  • 8 Gift LJ, Gaughan EM, DeBowes RM. et al The influence of intratendinous sodium hyaluronate on tendon healing in horses. Vet Comp Orthop Traumatol 1992; 5: 151-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Verbruggen G, Veys EM. Influence of sulfated glycosminoglycans upon proteoglycan metabolism of the synovial lining cells. Acta Rhumatol 1977; 1: 75.
    PubMedGoogle Scholar
  • 10 Glade MJ. Polysulphated glycosaminoglycan accelerates net synthesis of collagen and glycosaminoglycans by arthritic equine cartilage tissues and chondrocytes. Am J Vet Res 1990; 51: 779-85.
    PubMedGoogle Scholar
  • 11 Burkhardt F, Ghosh P. Laboratory evaluation of glycosaminoglycan polysulfate ester for chondroprotective activity: a review. Curr Ther Res 1986; 40: 1034-53.
    PubMedGoogle Scholar
  • 12 Altman RD, Howell DS, Muniz OE. et al The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental arthritis: effects on collagenolytic enzyme activity and cartilage swelling properties. J Rheum 1987; 14: 127-9.
    PubMedGoogle Scholar
  • 13 Howell DS, Muniz OE, Carreno MR. Effect of glycosaminoglycan polysulfate ester on proteoglycan-degrading enzyme activity in an animal model of osteoarthritis. Adv Inflam Res 1986; 1: 197-201.
    PubMedGoogle Scholar
  • 14 Hamm D, Jones EW. Intra-articular (IA) and intramuscular (IM) treatment of noninfectious equine arthritis (DJD) with polysulphated glycosaminoglycan (PSGAG). Equine Vet Sci 1988; 8: 456-9.
    CrossrefPubMedGoogle Scholar
  • 15 Yovich JV, Trotter GW, Mcllwraith CW. et al Effects of polysulphated glycosaminoglycan on chemical and physical defects in equine articular cartilage. Am J Vet Res 1987; 48: 1407-14.
    PubMedGoogle Scholar
  • 16 Goodship AE, Silver IA, Wilson AM. Treatment of tendinitis in horses. Vet Rec 1992; 130: 58.
    PubMedGoogle Scholar
  • 17 Smith RKW. A case of superficial digital flexor tendinitis: ultrasonographic examination and treatment with intralesional polysulphated glycosaminoglycans. Equine Vet Educ 1992; 4: 280-5.
    CrossrefPubMedGoogle Scholar
  • 18 Sundqvist H, Forsskahl B, Kvist M. A promising novel therapy for achilles peritendinitis: double-blind comparison of glycosaminoglycan polysulfate and high-dose indomethacin. Int J Sports Med 1987; 8: 298-303.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Genovese RL, Rantanen NW, Hauser ML. et al Diagnostic ultrasonography of equine limbs. Vet Clin N Amer: Equine Pract 1986; 2: 145-226.
    PubMedGoogle Scholar
  • 20 Spaulding K. Ultrasonic anatomy of the tendons and ligaments in the distal metacarpal- metatarsal region of the equine limb. Vet Radiol 1984; 25: 155-6.
    CrossrefPubMedGoogle Scholar
  • 21 Wood AKW, Polansky M, Kundel HL. et al. Equine tendon and ligament sonography: current concepts and future directions, in Proceedings, 38th Annu Meet Am Assoc Equine Pract. 1992: 253-64.
    Google Scholar
  • 22 Nicoll RG, Wood AKW, Rothwell TLW. Ultrasonographical and pathological studies of equine superficial digital flexor tendons; initial observations including tissue characterization by analysis of image grey scale, in a thoroughbred gelding. Equine Vet J 1992; 24: 318-20.
    CrossrefPubMedGoogle Scholar
  • 23 Riley GP, Harrall RL. Constant CR. et al Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1994; 53: 367-76.
    CrossrefPubMedGoogle Scholar
  • 24 Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991; 71: 481-539.
    CrossrefPubMedGoogle Scholar
  • 25 Burba DJ, Collier MA, Default LE. et al In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulphated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993; 13: 696-703.
    CrossrefPubMedGoogle Scholar
  • 26 Reid T, and Flint MH. Changes in glycosaminoglycan content of healing rabbit tendon. J Embyol Exp Morphol 1974; 31: 489-95.
    PubMedGoogle Scholar
  • 27 Merrilees MJ, Tiang KM, Scott L. Changes in collagen fibril diameters across artery walls including a correlation with glycosaminoglycan content. Conn Tiss Res 1987; 16: 237-57.
    CrossrefPubMedGoogle Scholar
  • 28 Piening C, Riederer-Henderson MA. Neutral metalloprotease from tendons. J Orthop Res 7: 228-34.
    PubMedGoogle Scholar
  • 29 Biaci A, Fehr K. Inhibition of human lysosomal elastase by arteparon. Proc 9th Europ Congr Rheumatol. Basle: Eular Publ Co; 1979: 19-26.
    Google Scholar